Variability in contrast agent uptake by different but similar stem cell types

por Ketkar-Atre A, Struys T, Soenen SJ, Lambrichts I, Verfaillie CM, De Cuyper M, Himmelreich U
Publicado 2013

Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging

por D’Hollander A, Mathieu E, Jans H, Vande Velde G, Stakenborg T, Van Dorpe P, Himmelreich U, Lagae L
Publicado 2016

Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes

por Garcia Ribeiro RS, Belderbos S, Danhier P, Gallo J, Manshian BB, Gallez B, Bañobre M, de Cuyper M, Soenen SJ, Gsell W, Himmelreich U
Publicado 2019